Motrin Ibibuprofen

According to the FDA label: Uses • temporarily relieves minor aches and pains due to: • headache • muscular aches • minor pain of arthritis • toothache • backache • the common cold • menstrual cramps • temporarily reduces fever

198,012 adverse event reports submitted to the FDA (1998–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Motrin Ib in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Motrin Ib adverse event reports by reporter sex
SexReports
Female115,650
Male62,981
Unknown605

By Age Group

View age group data as a table
Motrin Ib adverse event reports by reporter age group
Age groupReports
0-1712,808
18-3421,887
35-4932,352
50-6437,725
65-7418,877
75+12,592

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Motrin Ib. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Motrin Ib adverse event reports by reported outcome
OutcomeReports
Other Serious94,086
Hospitalization69,646
Non-Serious54,736
Death16,009
Life-Threatening12,797
Disability8,968

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Motrin Ib. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Motrin Ib adverse event reports by year
YearReports
19981
20012
20021
20035
20041,623
20052,146
20062,063
20072,133
20081,795
20092,779
20104,072
20115,736
20127,117
20136,886
20146,623
20159,399
201612,802
201711,567
201815,836
201916,872
202015,638
202115,403
202214,824
202313,925
202412,829
202512,904
2026 (partial)3,031

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Motrin Ib

In FDA adverse event reports that mention Motrin Ib, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026